CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹25,644 Cr | ₹21,439 Cr | ₹18,057 Cr | ₹15,669 Cr | ₹13,537 Cr |
What is the latest Profit & Loss Account Balance ratio of CIPLA ?
Year | Profit & Loss Account Balance |
---|---|
Mar2025 | ₹25,644 Cr |
Mar2024 | ₹21,439 Cr |
Mar2023 | ₹18,057 Cr |
Mar2022 | ₹15,669 Cr |
Mar2021 | ₹13,537 Cr |
How is Profit & Loss Account Balance of CIPLA Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2025 | ₹25,644 Cr | 19.62 | |
Mar2024 | ₹21,439 Cr | 18.73 | |
Mar2023 | ₹18,057 Cr | 15.24 | |
Mar2022 | ₹15,669 Cr | 15.75 | |
Mar2021 | ₹13,537 Cr | - |
Compare Profit & Loss Account Balance of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹121,962.7 Cr | 1.8% | 2% | -2.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,809.0 Cr | 1.4% | -0.8% | 13.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,808.0 Cr | 1.4% | -1.7% | 45.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,905.0 Cr | 1.1% | 7.9% | 11.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,174.0 Cr | 1.8% | 1.6% | 12.3% | Stock Analytics | |
MANKIND PHARMA | ₹95,299.1 Cr | -0.6% | -5.9% | 6.2% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 1.8% |
2% |
-2.5% |
SENSEX | 1.6% |
0.7% |
6.8% |
You may also like the below Video Courses